Connect with us

Lucrative stock opportunity as the MJ space experiences explosive growth in the US

Gage Growth has a competitive edge in a blossoming industry.
The post Lucrative stock opportunity as the MJ space experiences explosive growth in the US appeared first on Value the Markets.

Published

3 years ago

on

A lucrative investment opportunity with high margins and explosive growth!

GAGE GROWTH CORP. CSE:GAGE | OTC:GAEGF

Cannabis stocks are back in vogue as legalization spreads and brands gain market share. One promising investment opportunity is Gage Growth Corp. The firm is growing at an explosive pace, margins are going up significantly, and top-notch brands are requesting to be brought on board.

The MJ space is a blossoming industry shifting from the fragmented stage into a more streamlined and established position.

The companies that will thrive and survive are likely to be servicing the entire supply chain from R&D to distribution and sale of medical and recreational MJ. And this is precisely why Gage Growth has a competitive edge.

Its superior quality of goods is paramount in Gage Growth’s ambition to cultivate the best reputation and customer relations possible.

And the numbers tell us this strategy is working.

Impressive sales growth

In 2020, Gage Growth’s revenue rose an outstanding 1,972% year-over-year. And in Q420 it climbed 615% year-over-year.

This year, its impressive growth rate continues with record revenue of $17.6 million in Q121.

That’s a massive increase of 219% over their Q1 numbers for last year and 67.9% sequentially.

Download our new report to discover why this could be the most exciting phase for investors in Gage Growth Corp.

Gage Growth already has impressive profit margins, but with its cultivation yields and efficiency increasing, there’s room for even more profit-taking.

It increases its cultivation yields and efficiency through its assets and from its contract grow partnerships.

Lucrative partnerships

One of the top brands Gage Growth is collaborating with includes the high-profile cult brand COOKIES.

With an international presence and loyal fanbase, COOKIES is one of the most authentic and revered lifestyle brands operating in the space today.

It was started by a top Bay Area rapper, Berner. And COOKIES also partners with several celebrities, including Snoop Dogg, Mike Epps, Wiz Khalifa, and Rick Ross.

Furthermore, its partnership with Gage Growth is exclusive in the Michigan area.

Most recently, the company announced its exclusive partnership with multi-platinum-selling, GRAMMY® Award and Golden Globe® Award-nominated recording artist Wiz Khalifa’s brand, Khalifa Kush (“KK”), to develop and launch a line of premium cannabis products in the state of Michigan.

This is another example of Gage Growth‘s ability to bring another high-caliber brand to the Michigan market, which is what makes them unique and differentiated from competitors.

Gage Growth has also partnered with other top brands, including Blue River, SLANG Worldwide, Lemonnade, Grandiflora Genetics, and Runtz.

These collaborations have helped the company hit the ground running by making an instant connection with consumers.

Its product lines for sale include more than 150 branded cannabis varieties and product lines.

The list is impressive, and there’s something for everyone. Indoor and sun-grown flower, pre-rolls, gel caps, vape carts, vape pens, rosin, wax, tinctures, capsules, transdermal patches, CBD flower, and much more.

But Gage Growth is also very excited about the growth of its in-house cultivation and production facilities.

Conquering Michigan

In 2018 Michigan became the first Midwest state to legalize marijuana for adult use. This gives consumers the confidence to try the products knowing safety and quality are assured.

And now, Gage Growth is well on the way to conquering Michigan as the favorite dispensary chain in town.

2020 was a phenomenal year for the firm, and this year, growth is exploding. In fact, it’s gone from operating two stores last year to nine today, with a further five dispensaries in its portfolio. The company is targeting to open 20 or more locations by year-end.

Gage Growth sells direct to consumers via its dispensaries. And it includes the very first COOKIES branded dispensary outside of California.

By focusing on the overall customer experience from seed to sale, the company can ensure high quality through its supply chain.

Better still, it has control of much higher margins than selling wholesale or just operating dispensaries.

Michigan is fast becoming a central MJ state. April data showed it was moving into the top three states in the pot industry, alongside California and Colorado.

The legalization of cannabis is taking the industry by storm. In fact, it’s projected to add a whopping $160 billion to the US economy by 2025.

Last year, Michigan sold $985 million worth of cannabis product sales – a 3.5x jump year-over-year.

And this year’s numbers are even more exciting, with sales predictions coming in at $1.85 billion when annualizing the April sales.

Furthermore, in Q1 of this year, Gage Growth achieved an average basket size of $158 per sale. That far exceeds Michigan’s statewide average of $85.

Gage Growth is successfully implementing its aggressive growth plan, and sales prove this is going well. In fact, it hopes to have increased its total cultivation capacity to 3,000lbs/month this summer and 7,000lbs/month by the end of the year.

Fostering happiness and freedom from chronic pain

GAGE GROWTH CORP. CSE:GAGE | OTC:GAEG

After the doom and gloom of the global pandemic and climate change worry, it’s no wonder depression and anxiety rates are rocketing.

Deemed a natural way to treat these problems, cannabis is fast becoming a popular solution.

More and more people are being given medical marijuana cards to get their much-needed medication quickly and legally.

As a result, Michigan is already thought to have over 250,000 medical marijuana patients registered.

The stigma surrounding MJ is waning, and regulation is easing. This is great news for mental health and cultural reform.

But that’s not all; cannabis is also being medically prescribed to provide much-needed chronic pain relief for long-term debilitating illnesses such as MS. Or as an alternative to opioid used in dealing with nerve damage and inflammation.

But cannabis is not a new solution to treat various ailments. In fact, way back in 1850, cannabis gained entry to the United States Pharmacopoeia as a medicine. This led to doctors recommending it as a treatment for depression, pain, and insomnia. It remained listed until 1942, by which time prohibition had crept into force.

Thankfully cannabis is now experiencing a renaissance and being recognized once more for its potent powers.

Savvy management team

Gage Growth’s CEO Fabian Monaco is a charismatic, likable character with a strong head for business. He’s a former investment banker with first-hand experience of taking an MJ company public.

With several years in the MJ game, he’s witnessed the industry shift from amateur free-for-all to established and credible brands gaining market share.

Along the way, he’s seen several large financing deals and acquisitions take place in the sector.

His hands-on and hardworking approach means he’s fully acquainted with business operations throughout the entire cannabis production process.

This quality experience thrilled and fascinated him, ultimately leading him to his current role at Gage Growth. He’s now been leading there for over three years, flanked by Gage Growth’s co-founders.

These co-founders are seasoned professionals in the cannabis space, and they, too, have gained a wealth of knowledge, experience, and connections in the sector.

Altogether, they run a tight ship with consumer experience always at the forefront of their ethos.

Even though Michigan is the team’s primary focus at this time, it’s got its sights set on becoming a multi-state operator with much more scope for expansion.

An undervalued acquisition target

Gage Growth has a $519 million fully diluted market cap. This seems significantly undervalued compared to its peers. It’s operating on an EV/ 2021 Sales value of ~3x, which is far below industry leaders.

Canopy Growth, for instance, operates on an EV/Sales ratio of 21.4x, and Tilray operates at 16.8x.

Download our special report on Gage Growth Corp.’s rapid rise in one of America’s top states in the industry and how early investors could profit

M&A action is prevalent in the cannabis sector as the leading players establish themselves and brands are brought together.

With its accelerated growth path, premium product, and enviable margins, Gage Growth makes a prime acquisition target.

Good times ahead

All-in-all, there’s a lot to like about Gage Growth’s vertically integrated business model.

It is now a leading operator in Michigan, which CEO, Fabian Monaco, believes will easily be among the top five largest cannabis markets in the United States this year.

Gage Growth has a high-quality portfolio of brands and licenses under its wing and profit margins far surpass wholesale MJ models.

On top of this, Gage Growth has been included in some of the leading cannabis-focused exchange-traded funds (ETF). This addition to the AdvisorShares Pure US Cannabis ETF (NYSE: MSOS) and Horizons US Marijuana Index ETF (NEO: HMUS) gives it serious credibility and enhanced status as a stock to watch.

Its share price is undervalued compared to industry peers, and its growth trajectory is both aggressive and impressive. The company has a solid team at the helm, steering it with credibility and integrity and a wealth of experience between them.

Accordingly, Gage Growth is an investment opportunity not to be missed in today’s green revolution, fusing the push for natural plant medicine and shifting drug policy.

Gage Growth’s end goal is to deliver Michigan’s best cannabis, and it’s well on the way to doing so.

IMPORTANT NOTICE AND DISCLAIMER

PAID ADVERTISEMENT

This communication is a paid advertisement. ValueTheMarkets is a trading name of Digitonic Ltd, and its owners, directors, officers, employees, affiliates, agents and assigns (collectively the “Publisher”) is often paid by one or more of the profiled companies or a third party to disseminate these types of communications. In this case, the Publisher has been compensated by Gage Growth Corp. to conduct investor awareness advertising and marketing and has paid the Publisher the equivalent of five hundred thousand US dollars to produce and disseminate this and other similar articles and certain related banner advertisements. This compensation should be viewed as a major conflict with the Publisher’s ability to provide unbiased information or opinion.

CHANGES IN SHARE TRADING AND PRICE

Readers should beware that third parties, profiled companies, and/or their affiliates may liquidate shares of the profiled companies at any time, including at or near the time you receive this communication, which has the potential to adversely affect share prices. Frequently companies profiled in our articles experience a large increase in share trading volume and share price during the course of investor awareness marketing, which often ends as soon as the investor awareness marketing ceases. The investor awareness marketing may be as brief as one day, after which a large decrease in share trading volume and share price may likely occur.

NO OFFER TO SELL OR BUY SECURITIES

This communication is not, and should not be construed to be, an offer to sell or a solicitation of an offer to buy any security.

INFORMATION

Neither this communication nor the Publisher purport to provide a complete analysis of any company or its financial position.

This communication is based on information generally available to the public and on an interview conducted with the company’s CEO, and does not contain any material, non public information. The information on which it is based is believed to be reliable. Nevertheless, the Publisher does not guarantee the accuracy or completeness of the information. Further, the information in this communication is not updated after publication and may become inaccurate or outdated. No reliance should be placed on the price or statistics information and no responsibility or liability is accepted for any error or inaccuracy. Any statements made should not be taken as an endorsement of analyst views.

NO FINANCIAL ADVICE

The Publisher is not, and does not purport to be, a broker-dealer or registered investment adviser or a financial adviser. The Publisher has no access to non-public information about publicly traded companies. The information provided is general and impersonal, and is not tailored to any particular individual’s financial situation or investment objective(s) and this communication is not, and should not be construed to be, personalized investment advice directed to or appropriate for any particular investor or a personal recommendation to deal or invest in any particular company or product. Any investment should be made only after consulting a professional investment advisor and only after reviewing the financial statements and other pertinent corporate information about the company. Further, readers are advised to read and carefully consider the Risk Factors identified and discussed in the advertised company’s SEC, SEDAR and/or other government filings. Investing in securities, particularly microcap securities, is speculative and carries a high degree of risk. Past performance does not guarantee future results.

FORWARD LOOKING STATEMENTS

This communication contains forward-looking statements, including statements regarding expected continual growth of the featured companies and/or industry. Statements in this communication that look forward in time, which include everything other than historical information, are based on assumptions and estimates by our content providers and involve risks and uncertainties that may affect the profiled company’s actual results of operations. These statements involve known and unknown risks, uncertainties and other important factors that could cause the actual results and performance to differ materially from any future results or performance expressed or implied in the forward-looking statements. These risks, uncertainties and other factors include, among others: the success of the profiled company’s operations; the size and growth of the market for the company’s products and services; the company’s ability to fund its capital requirements in the near term and long term; pricing pressures; changes in business strategy, practices or customer relationships; general worldwide economic and business conditions; currency exchange and interest rate fluctuations; government, statutory, regulatory or administrative initiatives affecting the company’s business.

INDEMNIFICATION/RELEASE OF LIABILITY

By reading this communication, you acknowledge that you have read and understand this disclaimer in full, and agree and accept that the Publisher provides no warranty in respect of the communication or the profiled company and accepts no liability whatsoever. You acknowledge and accept this disclaimer and that, to the greatest extent permitted under applicable law, you release and hold harmless the Publisher from any and all liability, damages, injury and adverse consequences arising from your use of this communication. You further agree that you are solely responsible for any financial outcome related to or arising from your investment decisions.

TERMS OF USE AND DISCLAIMER

By reading this communication you agree that you have reviewed and fully agree to the Terms of Use found here https://www.valuethemarkets.com/terms-conditions/ and acknowledge that you have reviewed the Disclaimer found here https://www.valuethemarkets.com/disclaimer/. If you do not agree to the Terms of Use, please contact valuethemarkets.com to discontinue receiving future communications.

INTELLECTUAL PROPERTY

All trademarks used in this communication are the property of their respective trademark holders. Other than valuethemarkets.com, the Publisher is not affiliated, connected, or associated with, and the communication is not sponsored, approved, or originated by, the trademark holders unless otherwise stated. No claim is made by the Publisher to any rights in any third-party trademarks other than valuethemarkets.com.

AUTHORS: VALUETHEMARKETS

valuethemarkets.com and Digitonic Ltd and our affiliates are not responsible for the content or accuracy of this article. The information included in this article is based solely on information provided by the company or companies mentioned above. This article does not provide any financial advice and is not a recommendation to deal in any securities or product. News and research are not recommendations to deal, and investments may fall in value so that you could lose some or all of your investment. Past performance is not an indicator of future performance.

ValueTheMarkets do not hold any position in the stock(s) and/or financial instrument(s) mentioned in the above piece. ValueTheMarkets have been paid to produce this piece by the company or companies mentioned above. Digitonic Ltd, the owner of valuethemarkets.com, has been paid for the production of this piece by the company or companies mentioned above.

The post Lucrative stock opportunity as the MJ space experiences explosive growth in the US appeared first on Value the Markets.

Read More

Related Topics:
Continue Reading

Government

Low Iron Levels In Blood Could Trigger Long COVID: Study

Low Iron Levels In Blood Could Trigger Long COVID: Study

Authored by Amie Dahnke via The Epoch Times (emphasis ours),

People with inadequate…

Published

4 hours ago

on

March 9, 2024

By

Low Iron Levels In Blood Could Trigger Long COVID: Study

Authored by Amie Dahnke via The Epoch Times (emphasis ours),

People with inadequate iron levels in their blood due to a COVID-19 infection could be at greater risk of long COVID.

(Shutterstock)

A new study indicates that problems with iron levels in the bloodstream likely trigger chronic inflammation and other conditions associated with the post-COVID phenomenon. The findings, published on March 1 in Nature Immunology, could offer new ways to treat or prevent the condition.

Long COVID Patients Have Low Iron Levels

Researchers at the University of Cambridge pinpointed low iron as a potential link to long-COVID symptoms thanks to a study they initiated shortly after the start of the pandemic. They recruited people who tested positive for the virus to provide blood samples for analysis over a year, which allowed the researchers to look for post-infection changes in the blood. The researchers looked at 214 samples and found that 45 percent of patients reported symptoms of long COVID that lasted between three and 10 months.

In analyzing the blood samples, the research team noticed that people experiencing long COVID had low iron levels, contributing to anemia and low red blood cell production, just two weeks after they were diagnosed with COVID-19. This was true for patients regardless of age, sex, or the initial severity of their infection.

According to one of the study co-authors, the removal of iron from the bloodstream is a natural process and defense mechanism of the body.

But it can jeopardize a person’s recovery.

“When the body has an infection, it responds by removing iron from the bloodstream. This protects us from potentially lethal bacteria that capture the iron in the bloodstream and grow rapidly. It’s an evolutionary response that redistributes iron in the body, and the blood plasma becomes an iron desert,” University of Oxford professor Hal Drakesmith said in a press release. “However, if this goes on for a long time, there is less iron for red blood cells, so oxygen is transported less efficiently affecting metabolism and energy production, and for white blood cells, which need iron to work properly. The protective mechanism ends up becoming a problem.”

The research team believes that consistently low iron levels could explain why individuals with long COVID continue to experience fatigue and difficulty exercising. As such, the researchers suggested iron supplementation to help regulate and prevent the often debilitating symptoms associated with long COVID.

“It isn’t necessarily the case that individuals don’t have enough iron in their body, it’s just that it’s trapped in the wrong place,” Aimee Hanson, a postdoctoral researcher at the University of Cambridge who worked on the study, said in the press release. “What we need is a way to remobilize the iron and pull it back into the bloodstream, where it becomes more useful to the red blood cells.”

The research team pointed out that iron supplementation isn’t always straightforward. Achieving the right level of iron varies from person to person. Too much iron can cause stomach issues, ranging from constipation, nausea, and abdominal pain to gastritis and gastric lesions.

1 in 5 Still Affected by Long COVID

COVID-19 has affected nearly 40 percent of Americans, with one in five of those still suffering from symptoms of long COVID, according to the U.S. Centers for Disease Control and Prevention (CDC). Long COVID is marked by health issues that continue at least four weeks after an individual was initially diagnosed with COVID-19. Symptoms can last for days, weeks, months, or years and may include fatigue, cough or chest pain, headache, brain fog, depression or anxiety, digestive issues, and joint or muscle pain.

Tyler Durden Sat, 03/09/2024 - 12:50

Read More

Continue Reading

Uncategorized

February Employment Situation

By Paul Gomme and Peter Rupert The establishment data from the BLS showed a 275,000 increase in payroll employment for February, outpacing the 230,000…

Published

5 hours ago

on

March 9, 2024

By

By Paul Gomme and Peter Rupert

The establishment data from the BLS showed a 275,000 increase in payroll employment for February, outpacing the 230,000 average over the previous 12 months. The payroll data for January and December were revised down by a total of 167,000. The private sector added 223,000 new jobs, the largest gain since May of last year.

Temporary help services employment continues a steep decline after a sharp post-pandemic rise.

Average hours of work increased from 34.2 to 34.3. The increase, along with the 223,000 private employment increase led to a hefty increase in total hours of 5.6% at an annualized rate, also the largest increase since May of last year.

The establishment report, once again, beat “expectations;” the WSJ survey of economists was 198,000. Other than the downward revisions, mentioned above, another bit of negative news was a smallish increase in wage growth, from $34.52 to $34.57.

The household survey shows that the labor force increased 150,000, a drop in employment of 184,000 and an increase in the number of unemployed persons of 334,000. The labor force participation rate held steady at 62.5, the employment to population ratio decreased from 60.2 to 60.1 and the unemployment rate increased from 3.66 to 3.86. Remember that the unemployment rate is the number of unemployed relative to the labor force (the number employed plus the number unemployed). Consequently, the unemployment rate can go up if the number of unemployed rises holding fixed the labor force, or if the labor force shrinks holding the number unemployed unchanged. An increase in the unemployment rate is not necessarily a bad thing: it may reflect a strong labor market drawing “marginally attached” individuals from outside the labor force. Indeed, there was a 96,000 decline in those workers.

Earlier in the week, the BLS announced JOLTS (Job Openings and Labor Turnover Survey) data for January. There isn’t much to report here as the job openings changed little at 8.9 million, the number of hires and total separations were little changed at 5.7 million and 5.3 million, respectively.

As has been the case for the last couple of years, the number of job openings remains higher than the number of unemployed persons.

Also earlier in the week the BLS announced that productivity increased 3.2% in the 4th quarter with output rising 3.5% and hours of work rising 0.3%.

The bottom line is that the labor market continues its surprisingly (to some) strong performance, once again proving stronger than many had expected. This strength makes it difficult to justify any interest rate cuts soon, particularly given the recent inflation spike.

Read More

Continue Reading

Spread & Containment

Another beloved brewery files Chapter 11 bankruptcy

The beer industry has been devastated by covid, changing tastes, and maybe fallout from the Bud Light scandal.

Published

5 hours ago

on

March 9, 2024

By

Before the covid pandemic, craft beer was having a moment. Most cities had multiple breweries and taprooms with some having so many that people put together the brewery version of a pub crawl.

It was a period where beer snobbery ruled the day and it was not uncommon to hear bar patrons discuss the makeup of the beer the beer they were drinking. This boom period always seemed destined for failure, or at least a retraction as many markets seemed to have more craft breweries than they could support.

Related: Fast-food chain closes more stores after Chapter 11 bankruptcy

The pandemic, however, hastened that downfall. Many of these local and regional craft breweries counted on in-person sales to drive their business. 

And while many had local and regional distribution, selling through a third party comes with much lower margins. Direct sales drove their business and the pandemic forced many breweries to shut down their taprooms during the period where social distancing rules were in effect.

During those months the breweries still had rent and employees to pay while little money was coming in. That led to a number of popular beermakers including San Francisco's nationally-known Anchor Brewing as well as many regional favorites including Chicago’s Metropolitan Brewing, New Jersey’s Flying Fish, Denver’s Joyride Brewing, Tampa’s Zydeco Brew Werks, and Cleveland’s Terrestrial Brewing filing bankruptcy.

Some of these brands hope to survive, but others, including Anchor Brewing, fell into Chapter 7 liquidation. Now, another domino has fallen as a popular regional brewery has filed for Chapter 11 bankruptcy protection.

Overall beer sales have fallen.

Image source: Shutterstock

Covid is not the only reason for brewery bankruptcies

While covid deserves some of the blame for brewery failures, it's not the only reason why so many have filed for bankruptcy protection. Overall beer sales have fallen driven by younger people embracing non-alcoholic cocktails, and the rise in popularity of non-beer alcoholic offerings,

Beer sales have fallen to their lowest levels since 1999 and some industry analysts

"Sales declined by more than 5% in the first nine months of the year, dragged down not only by the backlash and boycotts against Anheuser-Busch-owned Bud Light but the changing habits of younger drinkers," according to data from Beer Marketer’s Insights published by the New York Post.

Bud Light parent Anheuser Busch InBev (BUD) faced massive boycotts after it partnered with transgender social media influencer Dylan Mulvaney. It was a very small partnership but it led to a right-wing backlash spurred on by Kid Rock, who posted a video on social media where he chastised the company before shooting up cases of Bud Light with an automatic weapon.

Another brewery files Chapter 11 bankruptcy

Gizmo Brew Works, which does business under the name Roth Brewing Company LLC, filed for Chapter 11 bankruptcy protection on March 8. In its filing, the company checked the box that indicates that its debts are less than $7.5 million and it chooses to proceed under Subchapter V of Chapter 11. 

"Both small business and subchapter V cases are treated differently than a traditional chapter 11 case primarily due to accelerated deadlines and the speed with which the plan is confirmed," USCourts.gov explained. 

Roth Brewing/Gizmo Brew Works shared that it has 50-99 creditors and assets $100,000 and $500,000. The filing noted that the company does expect to have funds available for unsecured creditors. 

The popular brewery operates three taprooms and sells its beer to go at those locations.

"Join us at Gizmo Brew Works Craft Brewery and Taprooms located in Raleigh, Durham, and Chapel Hill, North Carolina. Find us for entertainment, live music, food trucks, beer specials, and most importantly, great-tasting craft beer by Gizmo Brew Works," the company shared on its website.

The company estimates that it has between $1 and $10 million in liabilities (a broad range as the bankruptcy form does not provide a space to be more specific).

Gizmo Brew Works/Roth Brewing did not share a reorganization or funding plan in its bankruptcy filing. An email request for comment sent through the company's contact page was not immediately returned.

 

Read More

Continue Reading

Trending